EFFICACY AND SAFETY OF ORALLY ADMINISTERED INTRAVENOUS MIDAZOLAM VERSUS A COMMERCIALLY PREPARED SYRUP

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SALEM KATAYOUN; KHOSHRANG HOSSEIN; KOUSHA MARYAM; HOSEINI MAHBOOBEH; RANJBAR MARZIEH; BANIASADI SHADI; SALAMZADEH JAMSHID

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Pediatrics Year:2015 | Volume:25 | Issue:3 Page(s): 1-7

Download Full-Text

View:

278

Download:

165

Cites:

Information Journal Paper

Title

EFFICACY AND SAFETY OF ORALLY ADMINISTERED INTRAVENOUS MIDAZOLAM VERSUS A COMMERCIALLY PREPARED SYRUP

Author(s)

Keywords

SEDATION

UNCOOPERATIVE PATIENT

ORAL MIDAZOLAM

CLINICAL TRIAL

CHILD

Abstract

Background: Among different categories of sedative agents, benzodiazepines have been prescribed for more than three decades to patients of all ages. The effective and predictable sedative and amnestic effects of benzodiazepines support their use in pediatric patients. Midazolam is one of the most extensively used benzodiazepines in this age group. Oral form of drug is the best accepted route of administration in CHILDren.Objectives: The purpose of this study was to compare the efficacy and safety of a commercially midazolam syrup versus orally administered IV midazolam in uncooperative dental patients. Second objective was to determine whether differences concerning SEDATION success can be explained by CHILD‘s behavioral problems and dental fear.Patients and Methods: Eighty eight uncooperative dental patients (Frankl Scales 1, 2) aged 3 to 6 years, and ASA I participated in this double blind, parallel randomized, controlled CLINICAL TRIAL. Midazolam was administered in a dose of 0.5 mg/kg for CHILDren under the age 5 and 0.2 mg/kg in patients over 5 years of age. Physiologic parameters including heart rate, respiratory rate, oxygen saturation and blood pressure were recorded. Behavior assessment was conducted throughout the course of treatment using Houpt SEDATION Rating Scale and at critical moments of treatment (injection and cavity preparation) by North Carolina Scale. Dental fear and behavioral problems were evaluated using CHILD Fear Schedule Survey-Dental Subscale (CFSS-DS), and Strength and Difficulties Questionnaire (SDQ). Independent t-test, Chi-Square, and Pearson correlation were used for statistical analysis.Results: Acceptable overall SEDATION ratings were observed in 90% and 86% of syrup and IV/Oral group respectively; Chi-Square P=0.5. Other domains of Houpt Scale including: sleep, crying and movement were also not significantly different between groups. Physiological parameters remained in normal limits during study without significant difference between groups.Conclusions: “Orally administered IV midazolam” preparation can be used as an alternative for commercially midazolam syrup.

Cites

No record.

References

ASSESSMENT OF A LOW DOSE OF IV MIDAZOLAM USED ORALLY FOR CONSCIOUS SEDATION IN PEDIATRIC DENTISTRY

Cite

APA: Copy

SALEM, KATAYOUN, KHOSHRANG, HOSSEIN, KOUSHA, MARYAM, HOSEINI, MAHBOOBEH, RANJBAR, MARZIEH, BANIASADI, SHADI, & SALAMZADEH, JAMSHID. (2015). EFFICACY AND SAFETY OF ORALLY ADMINISTERED INTRAVENOUS MIDAZOLAM VERSUS A COMMERCIALLY PREPARED SYRUP. IRANIAN JOURNAL OF PEDIATRICS, 25(3), 1-7. SID. https://sid.ir/paper/665181/en

Vancouver: Copy

SALEM KATAYOUN, KHOSHRANG HOSSEIN, KOUSHA MARYAM, HOSEINI MAHBOOBEH, RANJBAR MARZIEH, BANIASADI SHADI, SALAMZADEH JAMSHID. EFFICACY AND SAFETY OF ORALLY ADMINISTERED INTRAVENOUS MIDAZOLAM VERSUS A COMMERCIALLY PREPARED SYRUP. IRANIAN JOURNAL OF PEDIATRICS[Internet]. 2015;25(3):1-7. Available from: https://sid.ir/paper/665181/en

IEEE: Copy

KATAYOUN SALEM, HOSSEIN KHOSHRANG, MARYAM KOUSHA, MAHBOOBEH HOSEINI, MARZIEH RANJBAR, SHADI BANIASADI, and JAMSHID SALAMZADEH, “EFFICACY AND SAFETY OF ORALLY ADMINISTERED INTRAVENOUS MIDAZOLAM VERSUS A COMMERCIALLY PREPARED SYRUP,” IRANIAN JOURNAL OF PEDIATRICS, vol. 25, no. 3, pp. 1–7, 2015, [Online]. Available: https://sid.ir/paper/665181/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops